SCHEMBL5043210

SCHEMBL5043210

C=CCCCc1ccccc1NC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.43
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.42
SLC16A3 O15427 4/20 0.42
TSHR P16473 2/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.41
CYP2C19 P33261 3/20 0.41
POLB P06746 2/20 0.41
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13772834 0.91 ALDH1A1 (0.47) ALDH1A1HPGDMAPK1KDM4EHSD17B10
SCHEMBL30026550 0.81 ALDH1A1 (0.56) ALDH1A1HPGDMAPK1KDM4EHSD17B10
SCHEMBL10940633 0.81 ALDH1A1 (0.56) ALDH1A1HPGDMAPK1KDM4EHSD17B10
SCHEMBL8419387 0.81 ALDH1A1 (0.50) ALDH1A1HPGDMAPK1KDM4ESLC16A3
SCHEMBL8868044 0.81 ALDH1A1 (0.50) ALDH1A1HPGDMAPK1KDM4EHSD17B10
SCHEMBL1644901 0.81 MAPK1 (0.56) ALDH1A1HPGDMAPK1HSD17B10SLC16A3
SCHEMBL7473218 0.80 SLC16A3 (0.49) ALDH1A1HPGDMAPK1KDM4ESLC16A3
SCHEMBL11202040 0.80 ALDH1A1 (0.49) ALDH1A1HPGDMAPK1KDM4EHSD17B10
SCHEMBL607963 0.80 MAPK1 (0.54) ALDH1A1HPGDMAPK1SLC16A3TSHR
SCHEMBL8421130 0.80 ALDH1A1 (0.49) ALDH1A1HPGDMAPK1KDM4ESLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1889903-A1 Biocatalysts with amine acylase activity Novartis AG (CH) 2008-02-20 EP disclosed